Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
32.09
+2.88 (9.86%)
At close: Aug 13, 2025, 4:00 PM
33.68
+1.59 (4.95%)
After-hours: Aug 13, 2025, 7:41 PM EDT
Revenue by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2018 - 2019 |
| Multiomics | 254.55M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Multiomics Growth | 4.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sample Management Solutions | 318.65M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sample Management Solutions Growth | 2.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| B Medical | 83.13M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Products | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Products Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Services | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Services Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Core Products | 196.73M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Core Products Growth | 0.58% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sample Repository Solutions | 121.91M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sample Repository Solutions Growth | 5.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2018 - 2019 |
| North America | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 58.26M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 2.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific/ Other | 39.67M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific/ Other Growth | -12.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Revenue (Pre-FY2023) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa | 61.96M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom | 27.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom Growth | 26.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe | 102.77M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Growth | 15.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 366.21M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | -0.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2018 - 2019 |
| Sample Management Solutions Adjusted Operating Income | 10.84M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sample Management Solutions Adjusted Operating Income Growth | 214.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Multiomics Adjusted Operating Income | -8.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Multiomics Adjusted Operating Income Growth | 462.67% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| B Medical Systems Adjusted Operating Income | -5.67M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Product Adjusted Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Product Adjusted Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Services Adjusted Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Services Adjusted Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Organic Revenue Growth | -2.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|